Development of Artificial inTelligence based digitaL monitoring of rheumAtoid arthritis patientS (ATLAS)

Development of Artificial inTelligence based digitaL monitoring of rheumAtoid arthritis patientS (ATLAS) - ATLAS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54394

Enrollment

164

Registered

2021-12-29

Start date

2023-02-28

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheuma rheumatoid Arthritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >= 18 years - A diagnosis of RA existing for at least five years and meeting the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. (17) - Willing and able to independently provide written informed consent - Owns and is able to use a mobile device ( Android or iOS)

Exclusion criteria

Exclusion criteria: - Insufficient knowledge of the Dutch language to engage with the eHealth tool

Design outcomes

Primary

Measure	Time frame
Primary endpoint: proportion of patients in clinical disease remission: DAS28 joint score	—

Secondary

Measure	Time frame
- Evaluate differences in use of clinical services by comparing the number of - Clinic visits, - Hospitalizations, - Laboratory procedures, - Medication alteration (both intensification and tapering) and - Intra-articular joint injections - Patient & Provider Experiences: proportion of patients and providers who would recommend this platform to others (Net Promotor score: > 0: good, > 30: great, > 50: excellent); plus the System Usability Scale (SUS). - Proportion of patients with >= 20% increase in Quality of Life (VAS) at 12 months compared to baseline. ( Visual Analogue Scale (VAS): Quality of Life >= 2 points increase on a scale of 1-100) - Proportion of patients with >= 20% increase in Productivity (VAS) at 12 months compared to baseline. ( Visual Analogue Scale (VAS): Productivity >= 2 points increase on a scale of 1-100)	—

Measure

Time frame

- Evaluate differences in use of clinical services by comparing the number of - Clinic visits, - Hospitalizations, - Laboratory procedures, - Medication alteration (both intensification and tapering) and - Intra-articular joint injections - Patient & Provider Experiences: proportion of patients and providers who would recommend this platform to others (Net Promotor score: > 0: good, > 30: great, > 50: excellent); plus the System Usability Scale (SUS). - Proportion of patients with >= 20% increase in Quality of Life (VAS) at 12 months compared to baseline. ( Visual Analogue Scale (VAS): Quality of Life >= 2 points increase on a scale of 1-100) - Proportion of patients with >= 20% increase in Productivity (VAS) at 12 months compared to baseline. ( Visual Analogue Scale (VAS): Productivity >= 2 points increase on a scale of 1-100)

—

Countries

Netherlands

Outcome results